Long-Acting Somatostatin Analogue Safety Monitoring Protocol for Outpatients With Neuroendocrine Tumors

Somatostatin analogues (SSAs) are widely used in the long-term treatment of neuroendocrine tumors (NETs) and have a relatively favorable safety profile. However, SSAs are associated with specific side effects that are important to monitor. Currently, there is no standardized safety monitoring protoc...

Descripción completa

Detalles Bibliográficos
Autores principales: Gabrielsen, Jordan, Girone, Gianna, Bennett, Bonita, Jung, Anna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Harborside Press LLC 2019
Materias:
Quality Improvement
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7517774/
https://www.ncbi.nlm.nih.gov/pubmed/33391850
http://dx.doi.org/10.6004/jadpro.2019.10.7.2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7517774/
https://www.ncbi.nlm.nih.gov/pubmed/33391850
http://dx.doi.org/10.6004/jadpro.2019.10.7.2

Ejemplares similares